(2016)
The glycolytic enzyme enolase represents a plasminogen-binding protein on the surface of a wide variety of medically important fungal species.
Int J Med Microbiol 306(1),
59-68.
Dr. Teresia Hallström
AlumniPublikationen
(2016)
Conserved Patterns of Microbial Immune Escape: Pathogenic Microbes of Diverse Origin Target the Human Terminal Complement Inhibitor Vitronectin via a Single Common Motif.
PLOS ONE 11(1),
e0147709.
(2016)
BGA66 and BGA71 facilitate complement resistance of Borrelia bavariensis by inhibiting assembly of the membrane attack complex.
Mol Immunol 99,
407-424.
(2015)
Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack.
PLOS One 10(9),
e0137630.
(2015)
Binding of vitronectin and Factor H to Hic contributes to immune evasion of Streptococcus pneumoniae serotype 3.
Thromb Haemost 113(1),
125-142.
(2014)
Identification of a Haemophilus influenzae factor H-Binding lipoprotein involved in serum resistance.
J Immunol 192(12),
5913-5923.
(2014)
Versatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetes.
Infect Immun 82(1),
380-392.
(2014)
Tuf of Streptococcus pneumoniae is a surface displayed human complement regulator binding protein.
Mol Immunol 62(1),
249-264.
(2014)
A fine-tuned interaction between trimeric autotransporter haemophilus surface fibrils and vitronectin leads to serum resistance and adherence to respiratory epithelial cells.
Infect Immun 82(6),
2378-2389.
(2013)
Human factor H-related protein 2 (CFHR2) regulates complement activation.
PLOS One 8(11),
e78617.